tiprankstipranks
111 Inc (YI)
NASDAQ:YI

111 (YI) Stock Price & Analysis

239 Followers

YI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.97 - $3.36
Previous Close$1.02
Volume9.28K
Average Volume (3M)67.87K
Market Cap
$83.52M
Enterprise Value$503.16M
Total Cash (Recent Filing)¥922.65M
Total Debt (Recent Filing)¥279.46M
Price to Earnings (P/E)-1.6
Beta0.77
May 16, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.65
Shares Outstanding83,517,312
10 Day Avg. Volume46,893
30 Day Avg. Volume67,867
Standard Deviation0.23
R-Squared0.00767
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.19
Price to Sales (P/S)0.00600
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

0.00%0.08%0.98%98.95%
0.00%
Insiders
0.98% Other Institutional Investors
98.95% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

YI FAQ

What was 111 Inc’s price range in the past 12 months?
111 Inc lowest stock price was $0.97 and its highest was $3.36 in the past 12 months.
    What is 111 Inc’s market cap?
    Currently, no data Available
    When is 111 Inc’s upcoming earnings report date?
    111 Inc’s upcoming earnings report date is May 16, 2024 which is in 20 days.
      How were 111 Inc’s earnings last quarter?
      111 Inc released its earnings results on Mar 21, 2024. The company reported -$0.343 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.343.
        Is 111 Inc overvalued?
        According to Wall Street analysts 111 Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does 111 Inc pay dividends?
          111 Inc does not currently pay dividends.
          What is 111 Inc’s EPS estimate?
          111 Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does 111 Inc have?
          111 Inc has 47,993,240 shares outstanding.
            What happened to 111 Inc’s price movement after its last earnings report?
            111 Inc reported an EPS of -$0.343 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20.261%.
              Which hedge fund is a major shareholder of 111 Inc?
              Currently, no hedge funds are holding shares in YI
              ---

              111 Stock Smart Score

              4
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              111 Inc

              111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment engages in the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Cardinal Health
              McKesson
              Patterson Companies
              Henry Schein
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis